WeightSnap Research / KLOW peptide

What Is KLOW? The Peptide Blend Explained

KLOW is a four-peptide blend of GHK-Cu, BPC-157, TB-500, and KPV. Here is what each component is, why no two vendor vials are quite the same, and where each peptide actually stands with regulators.

WeightSnap Research · reference, not medical advice · last reviewed July 2026

Read this first. KLOW and its components are sold as research chemicals. None are FDA-approved as injectable medicines. This page explains what the blend is and cites what the peptides have been studied for; it is not medical advice, not a recommendation to use anything, and not a dosing protocol. Anything affecting your health belongs with a licensed provider.

KLOW is a name, not a formula

KLOW is a marketing label for a multi-peptide blend, the same way "Wolverine" or "GLOW" are. It most commonly refers to an 80mg freeze-dried vial containing 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, and 10mg KPV. The quickest way to describe it: KLOW is a GLOW blend (GHK-Cu, BPC-157, TB-500) with KPV added, which is where the K comes from.

The important word is "commonly." Because KLOW is a name rather than a standardized product, the exact amounts, the ratio between components, and even the total vial size differ from one vendor to the next. Two people who both say they are running KLOW can be working with meaningfully different vials. That single fact drives most of the confusion around the blend, and it is why any calculation has to start from the numbers printed on your own label.

What is in KLOW: the four components

Each of the four is its own peptide with its own history and its own body of (mostly preclinical) research. Here is the short version of what each one is.

ComponentCommon amountWhat it is
GHK-Cu50 mgA copper-bound tripeptide (glycyl-L-histidyl-L-lysine), first isolated from human plasma in 1973. Studied for wound healing, collagen production, and skin repair.
BPC-15710 mgA pentadecapeptide (15 amino acids) derived from a protein found in gastric juice. Studied in animal models for soft-tissue and gut repair and anti-inflammatory effects.
TB-50010 mgA synthetic fragment of thymosin beta-4, a protein present in most cells. Studied for cell migration and angiogenesis (new blood vessel formation).
KPV10 mgA tripeptide (lysine-proline-valine) from the tail end of alpha-MSH. Studied for anti-inflammatory activity via NF-kB signalling, without the pigmentation effects of its parent hormone.

A recurring theme in the research literature is that most of the human evidence is thin. GHK-Cu has the deepest track record, largely from topical skin studies. BPC-157 and TB-500 have a substantial animal literature but very little controlled human data. KPV is earlier still, with promising preclinical results in inflammation models (colitis, dermatitis) but no approved use. None of this is the same as proof that the blend does anything in people, and it is not a reason to use it.

The regulatory picture, component by component

This is the part that trips people up, because the four peptides do not all sit in the same place, and the ground has been moving. As of mid-2026:

GHK-Cu

GHK-Cu is the one with a genuine approved life, but in a specific form: as a topical cosmetic ingredient it is legal and widely sold, listed on skincare labels as "copper tripeptide-1." That is regulated as a cosmetic, not a drug. Injecting GHK-Cu is a completely separate regulatory category, and in that form it is not an approved medicine.

BPC-157 and TB-500

Neither is FDA-approved for any human use. Both were placed on the FDA's restricted list for compounding pharmacies (503A Category 2) in 2023 over concerns about impurities and limited human safety data, and their status has continued to shift through 2025 and 2026. Both are also on the World Anti-Doping Agency's prohibited list, so they matter for tested athletes. Treat any seller's claim that they are "now legal" with caution.

KPV

KPV is at the preclinical stage: real interest in the research world for inflammation, no approval, and no established human safety profile.

The honest summary: none of the four are approved injectable medicines. GHK-Cu is an approved cosmetic when used topically. The compounding rules around BPC-157 and TB-500 have been contested and changing, so this section is dated on purpose. If the regulatory status matters to you, check the current FDA position directly rather than trusting a vendor or a page like this one to be current.

How KLOW dosing math actually works

Because a blend has a fixed ratio baked into the vial, you cannot dose one component without dosing the others. Every draw contains all four at once, in proportion to the label. The practical question is not "how much do I take" (that is between a person and their provider) but "how much of each peptide is in a given draw."

The arithmetic is straightforward: each component's concentration is its label amount divided by the bacteriostatic water you add, and the volume you draw times each concentration gives the milligrams of each peptide per injection. One quirk worth knowing: GHK-Cu is dosed in the milligram range, while BPC-157, TB-500, and KPV are usually talked about in micrograms, so a single draw can deliver "2.5 mg" of one component and "500 mcg" of another.

Rather than do this by hand, the free peptide blend calculator takes your own vial label plus the units you draw and shows the amount of each component per injection, in the right units. For single-peptide vials, the reconstitution calculator covers the basic concentration and syringe-unit math. Both are arithmetic tools, not dosing advice.

A note from us

Full transparency: WeightSnap's founder is personally starting a KLOW protocol, which is part of why this reference exists. That first-hand experience is being documented separately, in his own words, on the blog rather than here, so this page can stay a neutral technical reference. If you want the personal side (why, how it's going, what the tracking looks like), follow along on the blog. WeightSnap the app handles blends natively, recording the per-component amount of every logged injection alongside vial supply.

Frequently asked questions

What is KLOW?

A marketing name for a multi-peptide blend, most commonly an 80mg vial of 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, and 10mg KPV. Amounts vary by vendor. Sold as a research chemical, not an approved medicine.

What is in KLOW?

GHK-Cu, BPC-157, TB-500, and KPV. It is essentially a GLOW blend (the first three) with KPV added.

Are the peptides in KLOW FDA approved?

As of mid-2026, none are approved as injectable medicines. GHK-Cu is an approved cosmetic ingredient topically. BPC-157 and TB-500 have faced FDA compounding restrictions with a status that keeps changing. KPV is preclinical. All are sold research-use-only.

Why do KLOW recipes differ between vendors?

It is a marketing name, not a standardized formula, so amounts and ratios vary. Always use the numbers on your own vial label.

How do you calculate a KLOW dose?

Each component's concentration is its label mg divided by the water added; the volume drawn times each concentration gives the mg of each peptide per injection. The blend calculator does this from your label. GHK-Cu is in mg; BPC-157, TB-500, and KPV are usually in mcg.

WeightSnap is a tracking tool, not medical advice. This page is a technical reference about a research-chemical blend and its components. It does not recommend using KLOW or any peptide, provides no dosing protocol, and should not replace guidance from a licensed healthcare provider. Regulatory details are accurate to the best of our knowledge as of July 2026 and are subject to change.